The University of Chicago Header Logo

Connection

Samuel G. Armato to Pleural Neoplasms

Back to Details
This is a "connection" page, showing publications Samuel G. Armato has written about Pleural Neoplasms.
Samuel G. Armato
Connection Strength
7.530
Pleural Neoplasms
  1. Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group. J Thorac Oncol. 2023 03; 18(3):278-298.
    View in: PubMed
    Score: 0.767
  2. Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2022 02; 164:76-83.
    View in: PubMed
    Score: 0.715
  3. Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma. Eur Radiol. 2019 Jun; 29(6):2981-2988.
    View in: PubMed
    Score: 0.583
  4. Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2019 04; 130:108-114.
    View in: PubMed
    Score: 0.579
  5. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1). J Thorac Oncol. 2018 07; 13(7):1012-1021.
    View in: PubMed
    Score: 0.557
  6. Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2016 11; 101:48-58.
    View in: PubMed
    Score: 0.496
  7. Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2015 Nov; 90(2):148-54.
    View in: PubMed
    Score: 0.459
  8. Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions. J Thorac Oncol. 2014 Aug; 9(8):1187-94.
    View in: PubMed
    Score: 0.429
  9. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2013 Nov; 82(2):190-6.
    View in: PubMed
    Score: 0.401
  10. Disease volumes as a marker for patient response in malignant pleural mesothelioma. Ann Oncol. 2013 Apr; 24(4):999-1005.
    View in: PubMed
    Score: 0.380
  11. Current state and future directions of pleural mesothelioma imaging. Lung Cancer. 2008 Mar; 59(3):411-20.
    View in: PubMed
    Score: 0.270
  12. Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. Acad Radiol. 2005 Oct; 12(10):1301-9.
    View in: PubMed
    Score: 0.232
  13. Computerized analysis of mesothelioma on CT scans. Lung Cancer. 2005 Jul; 49 Suppl 1:S41-4.
    View in: PubMed
    Score: 0.225
  14. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys. 2004 May; 31(5):1105-15.
    View in: PubMed
    Score: 0.211
  15. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study. Lung Cancer. 2019 12; 138:139-140.
    View in: PubMed
    Score: 0.154
  16. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. J Thorac Oncol. 2020 01; 15(1):29-49.
    View in: PubMed
    Score: 0.153
  17. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018 05 01; 36(13):1343-1373.
    View in: PubMed
    Score: 0.136
  18. North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study. J Thorac Oncol. 2016 08; 11(8):1335-1344.
    View in: PubMed
    Score: 0.121
  19. Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma. J Thorac Oncol. 2013 Apr; 8(4):478-86.
    View in: PubMed
    Score: 0.098
  20. Optimization of response classification criteria for patients with malignant pleural mesothelioma. J Thorac Oncol. 2012 Nov; 7(11):1728-34.
    View in: PubMed
    Score: 0.095
  21. Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol. 2012 Jul 10; 30(20):2509-15.
    View in: PubMed
    Score: 0.092
  22. Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma. Int Surg. 2012 Jan-Mar; 97(1):65-70.
    View in: PubMed
    Score: 0.090
  23. Computerized segmentation and measurement of malignant pleural mesothelioma. Med Phys. 2011 Jan; 38(1):238-44.
    View in: PubMed
    Score: 0.084
  24. Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication. Acad Radiol. 2011 Mar; 18(3):294-8.
    View in: PubMed
    Score: 0.083
  25. Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group. Lung Cancer. 2010 Oct; 70(1):1-6.
    View in: PubMed
    Score: 0.080
  26. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019 10; 14(10):1718-1731.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.